Belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company, today announced that its annual report on Form 20-F, containing audited consolidated ...
4h
Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in ...
There are clear inspirations from past heroes in places, but what makes Rook stand out stems from what this hero brings to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback